NO20023803D0 - Anvendelse av mirtazapin for behandling av sövnforstyrrelser - Google Patents
Anvendelse av mirtazapin for behandling av sövnforstyrrelserInfo
- Publication number
- NO20023803D0 NO20023803D0 NO20023803A NO20023803A NO20023803D0 NO 20023803 D0 NO20023803 D0 NO 20023803D0 NO 20023803 A NO20023803 A NO 20023803A NO 20023803 A NO20023803 A NO 20023803A NO 20023803 D0 NO20023803 D0 NO 20023803D0
- Authority
- NO
- Norway
- Prior art keywords
- mirtazapine
- treatment
- sleep disorders
- sleep
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200499 | 2000-02-11 | ||
PCT/EP2001/001221 WO2001058453A1 (en) | 2000-02-11 | 2001-02-06 | The use of mirtazapine for the treatment of sleep disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20023803D0 true NO20023803D0 (no) | 2002-08-09 |
NO20023803L NO20023803L (no) | 2002-10-09 |
NO328007B1 NO328007B1 (no) | 2009-11-09 |
Family
ID=8171013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20023803A NO328007B1 (no) | 2000-02-11 | 2002-08-09 | Anvendelse av mirtazapin for fremstilling av medikament for behandling av sovnforstyrrelser |
Country Status (25)
Country | Link |
---|---|
US (1) | US6933293B2 (no) |
EP (4) | EP2283840A1 (no) |
JP (1) | JP5039994B2 (no) |
KR (1) | KR20020069371A (no) |
CN (2) | CN1395487A (no) |
AR (1) | AR027394A1 (no) |
AT (1) | ATE317261T1 (no) |
AU (1) | AU780439B2 (no) |
BR (1) | BR0108261A (no) |
CA (1) | CA2396209C (no) |
CO (1) | CO5271706A1 (no) |
CZ (1) | CZ302368B6 (no) |
DE (1) | DE60117122T2 (no) |
DK (1) | DK1257278T3 (no) |
ES (1) | ES2258071T3 (no) |
HK (1) | HK1049122B (no) |
HU (1) | HUP0204391A3 (no) |
IL (2) | IL150290A0 (no) |
NO (1) | NO328007B1 (no) |
PE (1) | PE20011080A1 (no) |
PL (1) | PL206073B1 (no) |
RU (1) | RU2270680C2 (no) |
SK (1) | SK287396B6 (no) |
WO (1) | WO2001058453A1 (no) |
ZA (1) | ZA200205238B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152055A1 (en) * | 2003-01-30 | 2004-08-05 | Gliessner Michael J.G. | Video based language learning system |
UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
WO2005051349A2 (en) * | 2003-11-25 | 2005-06-09 | Aurobindo Pharma Ltd. | Pharmaceutical compositions of mirtazapine |
GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
WO2006041158A1 (ja) * | 2004-10-14 | 2006-04-20 | Daikin Industries, Ltd. | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
JP2006137748A (ja) * | 2004-10-14 | 2006-06-01 | Daikin Ind Ltd | 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置 |
JP2007284363A (ja) * | 2006-04-13 | 2007-11-01 | Daikin Ind Ltd | 噴霧剤 |
JP5635905B2 (ja) | 2007-04-11 | 2014-12-03 | メルク・シャープ・エンド・ドーム・ベー・フェー | ミルタザピンの調製方法 |
CA3013771C (en) | 2015-02-27 | 2024-01-02 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
EP0813873B1 (en) | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
PT1030667E (pt) * | 1997-11-14 | 2005-06-30 | Akzo Nobel Nv | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono |
-
2001
- 2001-02-06 WO PCT/EP2001/001221 patent/WO2001058453A1/en active IP Right Grant
- 2001-02-06 US US10/203,232 patent/US6933293B2/en not_active Expired - Lifetime
- 2001-02-06 EP EP10178745A patent/EP2283840A1/en not_active Withdrawn
- 2001-02-06 AT AT01902410T patent/ATE317261T1/de active
- 2001-02-06 EP EP05109549A patent/EP1658850A1/en not_active Withdrawn
- 2001-02-06 IL IL15029001A patent/IL150290A0/xx unknown
- 2001-02-06 DE DE60117122T patent/DE60117122T2/de not_active Expired - Lifetime
- 2001-02-06 CZ CZ20022330A patent/CZ302368B6/cs not_active IP Right Cessation
- 2001-02-06 EP EP05109547A patent/EP1656937A1/en not_active Ceased
- 2001-02-06 CN CN01803934A patent/CN1395487A/zh active Pending
- 2001-02-06 ES ES01902410T patent/ES2258071T3/es not_active Expired - Lifetime
- 2001-02-06 CN CNA2008100056868A patent/CN101229170A/zh active Pending
- 2001-02-06 CA CA002396209A patent/CA2396209C/en not_active Expired - Lifetime
- 2001-02-06 KR KR1020027009536A patent/KR20020069371A/ko not_active Application Discontinuation
- 2001-02-06 AU AU30247/01A patent/AU780439B2/en not_active Expired
- 2001-02-06 PL PL356721A patent/PL206073B1/pl not_active IP Right Cessation
- 2001-02-06 DK DK01902410T patent/DK1257278T3/da active
- 2001-02-06 EP EP01902410A patent/EP1257278B1/en not_active Expired - Lifetime
- 2001-02-06 JP JP2001557563A patent/JP5039994B2/ja not_active Expired - Lifetime
- 2001-02-06 BR BR0108261-2A patent/BR0108261A/pt not_active Application Discontinuation
- 2001-02-06 RU RU2002124141/15A patent/RU2270680C2/ru not_active IP Right Cessation
- 2001-02-06 HU HU0204391A patent/HUP0204391A3/hu unknown
- 2001-02-06 SK SK1144-2002A patent/SK287396B6/sk not_active IP Right Cessation
- 2001-02-08 PE PE2001000141A patent/PE20011080A1/es not_active Application Discontinuation
- 2001-02-09 AR ARP010100585A patent/AR027394A1/es unknown
- 2001-02-09 CO CO01009904A patent/CO5271706A1/es not_active Application Discontinuation
-
2002
- 2002-06-18 IL IL150290A patent/IL150290A/en not_active IP Right Cessation
- 2002-06-28 ZA ZA200205238A patent/ZA200205238B/en unknown
- 2002-08-09 NO NO20023803A patent/NO328007B1/no not_active IP Right Cessation
-
2003
- 2003-02-24 HK HK03101379.6A patent/HK1049122B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
NO20021845L (no) | Behandling av sovnforstyrrelser under anvendelse av desloratadin | |
NO20040097L (no) | Kombinasjoner for behandling av inflammatoriske forstyrrelser | |
NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
NO20043237L (no) | Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
HK1053058A1 (zh) | 普拉克索用於治療成癮性疾病的用途 | |
NO20041833L (no) | Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet | |
NO20033417L (no) | Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser | |
IS6137A (is) | Meðhöndlun á hugsýkistruflunum | |
NO20023448D0 (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
NO20023803L (no) | Anvendelse av mirtazapin for behandling av sövnforstyrrelser | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
NO20032156L (no) | Behandling av angstforstyrrelser | |
DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
NO20030717D0 (no) | Forbindelser for behandling av avhengighetsforstyrrelser | |
NO20005216D0 (no) | Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon | |
NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
NO20011189L (no) | Innretning for behandling av suspensjoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |